The current financial score of SBC Medical Group Holdings Inc is 9.31. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 49.19M, representing a year-over-year increase of 13.44%, while its net profit experienced a year-over-year increase of 334.98%.
The current valuation score of SBC Medical Group Holdings Inc is 7.74. Its current P/E ratio is 13.52, which is 201.20% below the recent high of 40.74 and 100.00% above the recent low of 0.00.
The current earnings forecast score of SBC Medical Group Holdings Inc is 8.67. The average price target is 8.75, with a high of 11.00 and a low of 7.00.
The current price momentum score of SBC Medical Group Holdings Inc is 4.03. Currently, the stock price is trading between the resistance level at 5.85 and the support level at 4.84, making it suitable for range-bound swing trading.
The current institutional shareholding score of SBC Medical Group Holdings Inc is 3.00. The latest institutional shareholding proportion is 1.56%, representing a quarter-over-quarter increase of 50.11%.
The current risk assessment score of SBC Medical Group Holdings Inc is 3.85. The company's beta value is 0.59. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.